US 11685746
Heteroaryl compounds for treating Huntington's disease
granted A61PA61P25/00A61P25/14
Quick answer
US patent 11685746 (Heteroaryl compounds for treating Huntington's disease) held by PTC THERAPEUTICS, INC. expires Mon Jun 22 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- PTC THERAPEUTICS, INC.
- Grant date
- Tue Jun 27 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 22 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61P, A61P25/00, A61P25/14, A61P25/28